J&J to Submit 10+ New Drugs by 2017

Johnson & Johnson (NYSE:JNJ), the world’s largest health care products manufacturer, is planning to submit more than 10 new drugs for approval by 2017, and improve 25 more, Bloomberg reported.

As quoted in the market news:

The wave of new therapies developed in-house and acquired from outside may keep J&J in its position as the fastest growing drugmaker in 2012 among the largest pharmaceutical companies.

Click here to read the full Bloomberg story